Уважаемые пользователи!

Данный сайт содержит информацию для людей с медицинским образованием и специалистов здравоохранения.
Входя на сайт, Вы подтверждаете свое согласие с Условиями использования и Политикой конфиденциальности.

Dear visitor!
This site contains medical information for healthcare professionals.
You can go further, if you agree with Terms and Conditions and Privacy Policy on this site.

Uroven' visfatina syvorotki krovi i ekspressiyagena visfatina (PBEF1) v podkozhnoyi vistseral'noy zhirovoy tkani u detey

Cover Page


The aim of this study was to investigate the characteristics of visfatin - PBEF1 - gene expression in subcutaneous and visceral
adipose tissue and serum levels of visfatin in children with relation to age and anthropometric parameters. The study included
52 patients (27 boys (52%), 25 girls (48%) aged from 2,5 to 18 years (13,8 [7,4-15,1] years)), who underwent an elective surgical intervention.
PBEF1 mRNA level was measured by real-time PCR and serum level of visfatin was quantified by immunoenzyme assay.
According to our study visfatin serum concentration in children with normal body weight was 9,2 [7,4-11,6] ng/ml, whereas in the
overweight group - 9,5 [7,5-11,1] ng/ml (p=0,5). No statistically significant gender difference in serum visfatin levels was observed.
No correlation between visfatin levels and age, pubertal stages and anthropometric indices in children was found. Statistically significant
differences in the level of gene expression between subcutaneous and visceral adipose tissue were found (р=0,002) in the
total group of children surveyed and children with normal weight, while there were no depot-specific differences in overweight children.
The study did not reveal any dependence of PBEF1 expression on age and sex of children. Expression of PBEF1 in adipose
tissue decreases with puberty (PBEF1VATγ=-0,24, р=0,02; PBEF1SATγ=-0,25, р=0,02). PBEF1 expression in adipose tissue was
not correlated with the serum visfatin (R=-0,06, р=0,6).

  1. Berndt J., Kloting N., Kralisch S. et al. Plasma visfatin concentrations and fat depot-specific mRNA expression in humans // Diabetes 2005; 54: 2911- 2916.
  2. Davutoglua M., Ozkayab M. et al. Plasma visfatin concentrations in childhood obesity: relationships to insulin resistance and anthropometric indi - ces // Swiss. Med. Wkly 2009; 139 (1-2): 22-27.
  3. Dedoussis G.V., Kapiri A., Samara A. et al. Visfatin: the link between inflammation and childhood obesity. // Diabetes Care 2009; 32(6): 71.
  4. Fukuhara A., Matsuda M., Nishizawa M. et al. Visfatin: a protein secreted by visceral fat that mimics the effects of insulin // Science 2005; 307: 426-30.
  5. Kim M.K., Lee J.H., Kim H. et al. Crystal structure of visfatin/pre-B cell colonyenhancing factor 1/nicotinamide phosphoribosyltransferase, free and in complex with the anti-cancer agent FK-866 // J. Mol. Biol. 2006; 362: 66-77.
  6. Kovacikova M., Vitkova M., Klimcakova E. et al. Visfatin expression in subcutaneous adipose tissue of pre-menopausal women: relation to hormones and weight reduction // Eur. J. Clin. Invest 2008; 38: 516-522.
  7. Martin P.R., Shea R.J., Mulks M.H. Identification of a plasmid-encoded gene from Haemo - philus ducreyi which confers NAD independence // J. Bacteriol. 2001; 183: 1168-74.
  8. Rongvaux A., Shea R.J., Mulks M.H., Gigot D., Urbain J., Leo O., Andris F. Pre-Bcell colony-enhancing factor, whose expression is up-regulated in activated lymphocytes, is a nicotinamide phosphoribosyltransferase, a cytosolic enzyme involved in NAD biosynthesis // Eur. J. Immunol. 2002; 32: 3225-34.
  9. Samal B. et al. Cloning and characterization of the cDNA encoding a novel human pre-B-cell colony-enhancing factor // Mol. Cell. Biol. 1994; 14(2): 1431-7.
  10. Sommer G. et al. Visfatin/PBEF/Nampt: structure, regulation and potential function of a novel adipokine // Clinical Science 2008; 115: 13-23.
  11. Varma V., Yao-Borengasser A., Rasouli N. et al. Human visfatin expression: relationship to insulin sensitivity, intramyocellular lipids, and inflammation // J. Clin. Endocrinol. Metab. 2007; 92: 666-672.
  12. Wang T., Zhang X., Bheda P., Revollo J.R., Imai S., Wolberger C. Structure of Nampt/PBEF/visfatin, a mammalian NAD+ biosynthetic enzyme // Nat. Struct. Mol. Biol. 2006; 13: 661-662.


Abstract - 675

PDF (Russian) - 1739

Copyright (c) 2010 Kosygina A.V., Sosunov V.V., Peterkova V.A., Dedov I.I.

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.